Fig. 1From: Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysisRisk-of-bias graph for randomized controlled trials and observational studiesBack to article page